Identification of bona fide alternative renin transcripts expressed along cortical tubules and potential roles in promoting insulin resistance in vivo without significant plasma renin activity elevation

Hypertension

Volumn 64, Issue 1, 2014, Pages 125-133

  Ishigami, Tomoaki ^a   Kino, Tabito ^a   Chen, Lin ^a   Minegishi, Shintaro ^a   Araki, Naomi ^a   Umemura, Masanari ^a   Abe, Kaito ^a   Sasaki, Rie ^a   Yamana, Hisako ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

alternative transcript; insulin resistance; renin

Indexed keywords

COMPLEMENTARY DNA; INSULIN; MESSENGER RNA; RENIN;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; BRAIN; GENE; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; KIDNEY CORTEX; KIDNEY TUBULE; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALTERNATIVE TRANSCRIPT; INSULIN RESISTANCE; RENIN;

ADRENAL GLANDS; ANIMALS; INSULIN RESISTANCE; KIDNEY; KIDNEY TUBULES; MICE; MICE, TRANSGENIC; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84902535694     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03394     Document Type: Article

References (46)

1. Inagami T. A memorial to Robert Tiegerstedt: the centennial of renin discovery. Hypertension. 1998;32: 953-957.
2. Bader M, Ganten D. It's renin in the brain: transgenic animals elucidate the brain renin angiotensin system. Circ Res. 2002;90: 8-10.
3. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation. 1994;89: 493-498.
4. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation. 1994;89: 458-470.
5. Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev. 1990;70: 1067-1116.
6. Sigmund CD, Gross KW. Structure, expression, and regulation of the murine renin genes. Hypertension. 1991;18: 446-457.
7. Saris JJ, Derkx FH, De Bruin RJ, Dekkers DH, Lamers JM, Saxena PR, Schalekamp MA, Jan Danser AH. High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol. 2001;280:H1706-H1715.
8. Clausmeyer S, Stürzebecher R, Peters J. An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria. Circ Res. 1999;84: 337-344.
9. Lee-Kirsch MA, Gaudet F, Cardoso MC, Lindpaintner K. Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing. Circ Res. 1999;84: 240-246.
10. Sinn PL, Sigmund CD. Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics. 2000;3: 25-31.
11. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010;12: 431-442.
12. Lavoie JL, Liu X, Bianco RA, Beltz TG, Johnson AK, Sigmund CD. Evidence supporting a functional role for intracellular renin in the brain. Hypertension. 2006;47: 461-466.
13. Sigmund CD. Divergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2012;302:R313-R320.
14. Holm I, Ollo R, Panthier JJ, Rougeon F. Evolution of aspartyl proteases by gene duplication: the mouse renin gene is organized in two homologous clusters of four exons. EMBO J. 1984;3: 557-562.
15. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108: 193-199.
16. Ushio-Yamana H, Minegishi S, Ishigami T, Araki N, Umemura M, Tamura K, Maeda E, Kakizoe Y, Kitamura K, Umemura S. Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension. Nephron Exp Nephrol. 2012;122: 95-102.
17. Sakai M, Tamura K, Tsurumi Y, Tanaka Y, Koide Y, Matsuda M, Ishigami T, Yabana M, Tokita Y, Hiroi Y, Komuro I, Umemura S. Expression of MAK-V/Hunk in renal distal tubules and its possible involvement in proliferative suppression. Am J Physiol Renal Physiol. 2007;292:F1526-F1536. (Pubitemid 46701880)
18. Rohrwasser A, Ishigami T, Gociman B, Lantelme P, Morgan T, Cheng T, Hillas E, Zhang S, Ward K, Bloch-Faure M, Meneton P, Lalouel JM. Renin and kallikrein in connecting tubule of mouse. Kidney Int. 2003;64: 2155-2162.
19. Gociman B, Rohrwasser A, Lantelme P, Cheng T, Hunter G, Monson S, Hunter J, Hillas E, Lott P, Ishigami T, Lalouel JM. Expression of angiotensinogen in proximal tubule as a function of glomerular filtration rate. Kidney Int. 2004;65: 2153-2160.
20. Zhang J, Preda DV, Vasquez KO, et al. A fluorogenic near-infrared imaging agent for quantifying plasma and local tissue renin activity in vivo and ex vivo. Am J Physiol Renal Physiol. 2012;303:F593-F603.
21. Kubota N, Terauchi Y, Tobe K, et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest. 2004;114: 917-927.
22. Dimitrijevic I, Rissler P, Luts L, Edvinsson L. Reduced expression of angiotensin II and angiotensin receptor type 1 and type 2 in resistance arteries from nasal lesions in granulomatosis with polyangiitis (Wegener's granulomatosis). Scand J Rheumatol. 2011;40: 448-452.
23. Shababi M, Habibi J, Ma L, Glascock JJ, Sowers JR, Lorson CL. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. J Mol Cell Cardiol. 2012;52: 1074-1082.
24. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109: 1417-1427.
25. Ichihara A, Hayashi M, Hirota N, Okada H, Koura Y, Tada Y, Kaneshiro Y, Tsuganezawa H, Saruta T. Angiotensin II type 2 receptor inhibits prorenin processing in juxtaglomerular cells. Hypertens Res. 2003;26: 915-921.
26. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T, Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest. 2004;114: 1128-1135.
27. Nguyen G. Renin and prorenin receptor in hypertension: what's new? Curr Hypertens Rep. 2011;13: 79-85.
28. Riediger F, Quack I, Qadri F, et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol. 2011;22: 2193-2202.
29. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, Kurauchi-Mito A, Bokuda K, Narita T, Oshima Y, Sakoda M, Tamai Y, Sato H, Fukuda K, Itoh H. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res. 2010;107: 30-34.
30. Clausmeyer S, Reinecke A, Farrenkopf R, Unger T, Peters J. Tissue- specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology. 2000;141: 2963-2970.
31. Morris BJ. New possibilities for intracellular renin and inactive renin now that the structure of the human renin gene has been elucidated. Clin Sci (Lond). 1986;71: 345-355.
32. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, Thomas J, Xiao S, Ishigami T, Herrmann T, Terreros DA, Ward K, Lalouel JM. Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse. Hypertension. 2002;39: 1007-1014.
33. Abel KJ, Gross KW. Physical characterization of genetic rearrangements at the mouse renin loci. Genetics. 1990;124: 937-947.
34. Dickinson DP, Gross KW, Piccini N, Wilson CM. Evolution and variation of renin genes in mice. Genetics. 1984;108: 651-667.
35. Yamauchi T, Nagahama M, Watanabe T, Ishizuka Y, Hori H, Murakami K. Site-directed mutagenesis of human prorenin. Substitution of three arginine residues in the propeptide with glutamine residues yields active prorenin. J Biochem. 1990;107: 27-31.
36. Mercure C, Thibault G, Lussier-Cacan S, Davignon J, Schiffrin EL, Reudelhuber TL. Molecular analysis of human prorenin prosegment variants in vitro and in vivo. J Biol Chem. 1995;270: 16355-16359.
37. Morales R, Watier Y, Böcskei Z. Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor. J Mol Biol. 2012;421: 100-111.
38. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344: 541-544.
39. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 1994;23: 422-427.
40. Tokita Y, Franco-Saenz R, Mulrow PJ, Ganten D. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27. Endocrinology. 1994;134: 253-257.
41. Manrique C, Lastra G, Habibi J, Pulakat L, Schneider R, Durante W, Tilmon R, Rehmer J, Hayden MR, Ferrario CM, Whaley-Connell A, Sowers Jr. Nebivolol improves insulin sensitivity in the TGR(mREN2)27 rat. Metabolism. 2011;60: 1757-1766.
42. Wei Y, Sowers JR, Clark SE, Li W, Ferrario CM, Stump CS. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase. Am J Physiol Endocrinol Metab. 2008;294:E345-E351. (Pubitemid 351231460)
43. Wei Y, Whaley-Connell AT, Chen K, Habibi J, Uptergrove GM, Clark SE, Stump CS, Ferrario CM, Sowers Jr. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension. 2007;50: 384-391.
44. Ma L, Gul R, Habibi J, Yang M, Pulakat L, Whaley-Connell A, Ferrario CM, Sowers Jr. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat. Am J Physiol Heart Circ Physiol. 2012;302:H2341-H2351.
45. Johnson MS, DeMarco VG, Heesch CM, Whaley-Connell AT, Schneider RI, Rehmer NT, Tilmon RD, Ferrario CM, Sowers Jr. Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat. Am J Physiol Heart Circ Physiol. 2011;301:H1540-H1550.
46. Wei Y, Clark SE, Morris EM, Thyfault JP, Uptergrove GM, Whaley-Connell AT, Ferrario CM, Sowers JR, Ibdah JA. Angiotensin ii- induced nonalcoholic fatty liver disease is mediated by oxidative stress in transgenic TGR(mREN2)27 (ren2) rats. J Hepatol. 2008;49: 417-428.